Literature DB >> 30246110

Synthesis and characterization of new dialkylacylphosphonylhydrazones.

Henriqueta Talita Guimarães Barboza1, Antonio Gomes Soares1, Otniel Freitas-Silva1, João Batista Neves DaCosta2.   

Abstract

The present work refers to the synthesis of novel dialkylacylphosphonylhydrazones that occurs in three reaction steps: the first one is the synthesis of different dialkyl acetate phosphonoacetates obtained by the reaction of ethyl bromoacetate with the trialkyl phosphite of interest. The second one is the synthesis of acetic diethoxyphosphonylhydrazines which is from the reaction between the synthesized dialkyl phosphonoacetates and hydrazine. The third and final steps is the condensation of acetic diethoxyphosphonylhydrazides with different heterocyclic aldehydes. In total, 17 unpublished compounds, namely 1 to 17 (Table 1) were obtained with a diastereoisomeric mixture of the preferential conformation E and all the compounds were characterized by 1-H and 13-C and 31-P NMR, infrared (IR) and mass spectroscopy (MS). This work presents the characterization data of these compounds.

Entities:  

Year:  2018        PMID: 30246110      PMCID: PMC6146382          DOI: 10.1016/j.dib.2018.08.073

Source DB:  PubMed          Journal:  Data Brief        ISSN: 2352-3409


Specifications Table Value of the data The synthesis of these dialkylacylphosphonylhydrazones is interesting because of the potential biological activity of the clusters present in the structures as acylidrazones (—CO—NH—N). The dialkylacylphosphonylhydrazones have applications ranging from medicinal compounds and agrochemicals up to functional materials and considering that organophosphates present effective agricultural protection. These compounds have potential drug action to combat Alzheimer׳s disease, where acetylcholinesterase inhibitor drugs are used. Initial studies have shown inhibition of the enzyme acetylcholinesterase, target of the drugs used for Alzheimer׳s disease. However, further studies should be conducted in order to verify their action without compromising human health. The steps to synthesize these compounds and their characterization are easily performed in the laboratory and there are a range of other products that can be obtained through this synthetic route.

Data

The synthesized dialkylphosphonylacylidrazones compounds are novel and were characterized by 1-H, 13-C and 31-P NMR as well as infrared (IR) and mass spectroscopy (MS). Due to the mixture of diastereoisomer obtained, duplications of the results in the presented spectra were observed. The ratio of the diastereoisomers is described in Table 9, which is preferred for the diastereoisomer E due to the prior works [1], [2], [3], [4], [5], [6], [7] (Fig. 1, Fig. 2, Fig. 3, Fig. 4, Fig. 5, Fig. 6).
Table 9

Ratio of the diastereoisomers in the mixture.

CompoundsMix of diastereomericCompoundsMix of diastereomeric
11:0.6101:0.5
21:0.6111:0.3
31:0.3121:0.6
41: 0.5131:0.75
51:0.4141:0.7
61:0.4151:0.9
71:0.6161:0.4
81:0.8171:0.4
91:0.7
Fig. 1

Compounds described in Table 2.

Fig. 2

Compounds described in Table 3.

Fig. 3

Compounds described in Table 4.

Fig. 4

Compounds described in Table 5.

Fig. 5

Compounds described in Table 6.

Fig. 6

Compounds described in Table 7.

IR data of the compounds synthesized in cm-1. * Insufficient sample to perform this analysis. 1-H NMR δ (ppm) data of the compounds synthesized from the reaction of intermediate III and aldehydes. : Results obtained with DMSO as solvent, others results were obtained in CDCl3. 1-H NMR δ (ppm) data of the compounds synthesized from the reaction of intermediate III and isatins. Results obtained with CDCl3 as solvent. 1-H NMR δ (ppm) data of the compounds synthesized from the reaction of intermediate IV with aldehydes and nitroisatin. Results obtained with DMSO as solvent. •δ (ppm) relative to H of the isatin ring NHCO, as shown in Table 6. Compound 16 is the only isatin derivative in this Table; all the others are aldehyde derivatives.
Table 6

13- C NMR δ (ppm) data of the compounds synthesized from the reaction of intermediate III and isatins.

*Results obtained with DMSO as solvent, the other results were obtained in CDCl3.

13- C NMR δ (ppm) data of the compounds synthesized from the reaction of intermediate III and aldehydes. : Results obtained with CDCl3 as solvent. NA indicates that the said signal does not show in the spectrum. 13- C NMR δ (ppm) data of the compounds synthesized from the reaction of intermediate III and isatins. *Results obtained with DMSO as solvent, the other results were obtained in CDCl3. 13-C NMR δ (ppm) data of the compounds synthesized from the reaction of intermediate IV and aldehydes. Results obtained in DMSO as solvent. NA indicates that the said signal does not appear in the spectrum. Compound 16 is a compound derived from the reaction with nitroisatin. 31- P NMR δ (ppm) data of the compounds synthesized. Results obtained with DMSO as solvent, others results were obtained in CDCl3. Ratio of the diastereoisomers in the mixture. Mass data of the synthesized compounds. *There was no result in the mass spectrum. Compounds described in Table 2.
Table 2

1-H NMR δ (ppm) data of the compounds synthesized from the reaction of intermediate III and aldehydes.

: Results obtained with DMSO as solvent, others results were obtained in CDCl3.

Compounds described in Table 3.
Table 3

1-H NMR δ (ppm) data of the compounds synthesized from the reaction of intermediate III and isatins.

Results obtained with CDCl3 as solvent.

Compounds described in Table 4.
Table 4

1-H NMR δ (ppm) data of the compounds synthesized from the reaction of intermediate IV with aldehydes and nitroisatin.

Results obtained with DMSO as solvent. •δ (ppm) relative to H of the isatin ring NHCO, as shown in Table 6. Compound 16 is the only isatin derivative in this Table; all the others are aldehyde derivatives.

Compounds described in Table 5.
Table 5

13- C NMR δ (ppm) data of the compounds synthesized from the reaction of intermediate III and aldehydes.

: Results obtained with CDCl3 as solvent. NA indicates that the said signal does not show in the spectrum.

Compounds described in Table 6. Compounds described in Table 7.
Table 7

13-C NMR δ (ppm) data of the compounds synthesized from the reaction of intermediate IV and aldehydes.

Results obtained in DMSO as solvent. NA indicates that the said signal does not appear in the spectrum. Compound 16 is a compound derived from the reaction with nitroisatin.

Experimental design, materials and methods

Synthesis of dialkyl ethyl phosphonoacetate: triethyl phosphonoacetate (I) and dibutyl ethyl phosphonoacetate (II) (reaction intermediates to prepare intermediates III and IV) [5].

General procedure

In a 50 mL round bottom flask equipped with a reflux condenser provided with a bubbler, ethyl α-bromoacetate and triethyl or tributyl phosphite are added in a slight excess to ensure the total consumption of ethyl α-bromoacetate. The reaction mixture was kept under reflux and with magnetic stirring for 6 h at 100 ° C. At the end of the reaction the solution was subjected to vacuum on the rotary evaporator for 5 h at a temperature of 80 ° C in order to remove the excess of the remaining reagent. Synthesis of dialkyl-2-hydrazino-2-oxyethyl: diethyl-2-hydrazino-2-oxyethyl phosphonate (III) and diethyl-2-hydrazino-2-oxyethyl phosphonate (IV) (reaction intermediates to prepare diethoxyphosphonyl-n-acylhydrazones [5] (Table 8, Table 10).
Table 8

31- P NMR δ (ppm) data of the compounds synthesized.

Compounds31 P NMR (m/m) (coupled)31 P NMR (s/s) (uncoupled)
121.20; 22.4021.20; 22.40
221.23; 22.3321.23; 22.33
320.98; 22.0920.98; 22.09
421.24; 22.2916.47; 17.56a
519.95; 20.1019.94; 20.08
620.08; 20.1920.04; 20.19
720.20; 20.5820.20; 20.58
821.15; 22.0921.13; 22.09
921.49; 21.8021.49; 21.80
1021.15; 22.3521.16; 22.35
1121.27; 22.1221.26; 22.12
1221.57; 21.9221.57; 21.92
13a21.63; 21.9121.63; 21.91
1421.48; 21.80
15a21.49; 21.8721.49; 21.87
16a20.66; 20.1720.66; 20.17
17a20.51; 21.2820.49; 21.26

Results obtained with DMSO as solvent, others results were obtained in CDCl3.

Table 10

Mass data of the synthesized compounds.

CompoundsMolecular massm/z (%)
1328329 (3), 195 (14), 177 (50), 151 (64), 125 (92), 123 (100), 109 (52), 97 (46), 81 (31), 59 (35).
2342343 (4), 195 (32), 168 (50), 164 (50), 151 (77), 125 (100), 97 (50), 81 (38), 59 (39).
3367169 (35), 151 (33), 141 (15), 123 (100), 105 (29), 97 (64), 81 (49), 65 (35).
4302303 (5), 302 (22), 168 (22), 151 (31), 125 (38), 124 (100), 123 (45), 109 (37), 97 (20), 81 (26), 59 (13).
5357357 (5), 329 (18), 281 (11), 207 (17), 179 (37), 152 (86), 151 (40), 123 (100), 81 (55), 65 (17).
6339329 (18), 281 (9), 207 (14), 205 (17), 179 (37), 152 (85), 123 (100), 81 (53), 65 (17).
7384*
8299300 (1), 179 (<1), 152 (12), 120 (100), 109 (22), 92 (59), 65 (12).
9288289 (<1), 195 (13), 179 (14), 151 (45), 152 (25), 123 (68), 110 (100), 81 (36), 59 (14).
10304305 (4), 195 (30), 151 (77), 123 (100), 109 (72), 81 (47), 59 (31).
11432433 (1), 254 (100), 237 (53), 168 (42), 151 (57), 109 (37), 79 (19).
12384385 (1), 255 (13), 196 (14), 177 (33), 140 (88), 123 (100), 97 (86), 57 (21).
13358359 (6), 196 (11), 153 (14), 140 (72), 124 (100), 97 (52), 41 (23).
14344345 (2), 196 (14), 153 (17), 140 (70), 123 (94), 110 (100), 97 (55), 57 (21).
15360361 (2), 196 (23), 153 (24), 140 (91), 123 (100), 97 (77), 57 (23).
16440*
17395395 (1), 196 (20), 160 (38), 140 (84), 123 (100), 97 (62), 57 (22).

*There was no result in the mass spectrum.

The triethyl phosphonoacetate and the monohydrated hydrazine (64%) in a 50 mL round bottom flask are connected to a rotary evaporator. Then the reaction mixture is kept under vacuum at 50 ° C for 3 h. Synthesis of diethoxyphosphonyl-n-acylhydrazones. The solubilized intermediates III or IV, and the corresponding aldehydes dissolved in 3 mL of EtOH were added to a 50 mL round bottom flask, followed by two 2 drops of 37% HCl. The reaction mixture was kept under stirring for 5 h at room temperature. After the reaction time had elapsed, the reaction medium was poured into ice-cold distilled water and left in an ice bath for half an hour for precipitation to occur. At the end of this time it was vacuum filtered and air dried. When there was no precipitation, drops of 15% sodium bicarbonate solution were added to reach neutral pH. The resulting aqueous solution was extracted with dichloromethane (4 ×15 mL). Then anhydrous Na2 SO4 was added to the organic solution, after which it was filtered and evaporated in a rotary evaporator.
Subject areaChemistry
More specific subject areaOrganic chemistry, organophosphorus
Type of dataText file
How data was acquiredNMR (1H NMR (400 MHz), 13-C (100 MHz) and 31P (162 MHz) Bruker models Avance III 500 / Ultrashield 500 Plus and Avance II 400 / Ultrashield 400 Plus); mass spectroscopy (CG-MS - model QP2010 Plus - Shimadzu); infrared (FT-IR VERTEX 70).
Data formatAnalyzed
Experimental factorsFor the purification of the synthesized compounds, Biotagedo Isolera ™ Prime was used under the following analysis conditions: Ultra 10 g SNAP Cartridge - 25 μm silica stationary phase; wavelength detection mode; flow rate of 12 ml / min; Baseline correction, UV1 monitor readings at 254 nm and UV2 monitor readings at 365 nm and initial threshold of 20 mAU.
Experimental featuresIn the first step, in a 50 mL round bottom flask with a reflux condenser and bubbler, ethyl α-bromoacetate and triethyl or tributyl phosphite were reacted in slight excess. The reaction mixture remained under reflux and magnetic stirring for 6 h at 100 °C and was subsequently subjected to vacuum on the rotary evaporator for 5 h at 80 °C to remove excess of the remaining reagent. In the second step the triethyl phosphonoacetate, obtained above, was added to hydrazine monohydrate (64%) in a 50 mL round bottom flask, coupled to the rotary evaporator. The reaction mixture was kept under vacuum at 50 °C for 3 h. In the last step the diethoxyphosphonylhydrazides from step 2 was combined with the corresponding aldehyde, both previously dissolved in 3 mL of EtOH in a 50 mL round bottom flask. Then two 2 drops of 37% HCl were added. The reaction mixture was kept under stirring for 5 h at room temperature. After the reaction time had elapsed, the reaction medium was poured into ice-cold distilled water and left in an ice bath for half-an-hour for precipitation to occur. At the end of this time it was vacuum filtered and air dried. In cases where there was no precipitation, drops of 15% sodium bicarbonate solution were added to reach neutral pH. The resulting aqueous solution was treated with dichloromethane (4 ×15 mL). Finally, anhydrous Na2 SO4 was added to the organic solution, then it was filtered and evaporated in a rotary evaporator.
Data source location
Data accessibility
Table 1

IR data of the compounds synthesized in cm-1.

* Insufficient sample to perform this analysis.

  3 in total

1.  Design and synthesis of new (E)-cinnamic N-acylhydrazones as potent antitrypanosomal agents.

Authors:  Samir A Carvalho; Larisse O Feitosa; Márcio Soares; Thadeu E M M Costa; Maria G Henriques; Kelly Salomão; Solange L de Castro; Marcel Kaiser; Reto Brun; James L Wardell; Solange M S V Wardell; Gustavo H G Trossini; Adriano D Andricopulo; Edson F da Silva; Carlos A M Fraga
Journal:  Eur J Med Chem       Date:  2012-06-07       Impact factor: 6.514

2.  Synthesis and vasodilatory activity of new N-acylhydrazone derivatives, designed as LASSBio-294 analogues.

Authors:  Alexandre G Silva; Gisele Zapata-Sudo; Arthur E Kummerle; Carlos A M Fraga; Eliezer J Barreiro; Roberto T Sudo
Journal:  Bioorg Med Chem       Date:  2005-05-16       Impact factor: 3.641

3.  Studies towards the identification of putative bioactive conformation of potent vasodilator arylidene N-acylhydrazone derivatives.

Authors:  Arthur E Kümmerle; Juliana M Raimundo; Carla M Leal; Givanildo S da Silva; Tatiane L Balliano; Mariano A Pereira; Carlos A de Simone; Roberto T Sudo; Gisele Zapata-Sudo; Carlos A M Fraga; Eliezer J Barreiro
Journal:  Eur J Med Chem       Date:  2009-05-08       Impact factor: 6.514

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.